Drug Interactions Change Log
- Added voriconazole reference (CYP2C9 inhibition). -RLF on 11/29/07
- Added goldenseal as 2D6 inhibitor. -RLF on 2/13/08
- Added cinacalcet as 2D6 inhibitor, 3A4 substrate. -RLF on 3/6/08
- Added clopidogrel as CYP2C19 substrate. -RLF on 3/11/08
- Added lapatinib as 3A4 substrate. -RLF on 3/18/08
- Added sunitinib, torisel, sorafenib. -RLF on 4/20/09
- Added donepezil as 2D6 substrate. -RLF on 6/11/09
- Added duloxetine, fluvoxamine, haloperidol, nabumetone, tizanidine, triamterene, zileuton, zolmitriptan as 1A2 substrates. -RLF on 7/23/10
- Added telaprevir and boceprevir (both protease inhibitors) as 3A substrates and 3A inhibitors. - rvuppala on 5/24/11
- Added clonidine as 2D6 substrate. -RLL/tskaar on 9/27/11
